Literature DB >> 27860117

Development of a core outcome set for epilepsy in pregnancy (E-CORE): a national multi-stakeholder modified Delphi consensus study.

B H Al Wattar1, K Tamilselvan2, R Khan2, A Kelso2, A Sinha2, A M Pirie3,4, D McCorry4, K S Khan1,5,6, S Thangaratinam1,5.   

Abstract

OBJECTIVE: To develop a set of core outcomes for studies on pregnant women with epilepsy.
DESIGN: Delphi consensus study. POPULATION: Healthcare professionals, and patient representatives with lived experience of epilepsy in the UK.
METHODS: We used a modified Delphi method and a consultation meeting to achieve consensus. Potential outcomes were identified by systematic review, and were scored using a Likert scale anchored between 1 (least important) and 5 (most important). We included outcomes that scored ≥4 by >70% of participants, and outcomes that scored ≤2 by <15% of participants. MAIN OUTCOME MEASURES: Outcomes in studies on epilepsy in pregnancy.
RESULTS: Seventy-five healthcare professionals completed the first round, 48 (64%) completed the second round, and 37 (49%) completed the third round of the survey. Twenty-four patient representatives participated. The final core outcome set included 31 outcomes in three domains: neurological, offspring, and obstetric. Outcomes in the neurological domain were seizure control in pregnancy and postpartum, status epilepticus, maternal mortality, drowning, sudden unexpected death in epilepsy, postnatal depression, and quality of life. Offspring domain included congenital abnormalities (major and minor), fetal anticonvulsant syndrome, neurodevelopment, autism disorder, neonatal clinical complications, admission to a neonatal intensive care unit, and anthropometric measurements. The obstetric domain included live birth, stillbirth, miscarriage, ectopic, termination of pregnancy, admission to a high dependency or intensive care unit, breastfeeding, mode of delivery, preterm birth, pre-eclampsia, and eclampsia. Outcomes specific for studies on anti-epileptic drugs (AEDs) included maternal AED toxicity, AED compliance, neonatal withdrawal symptoms, and neonatal haemorrhagic disease.
CONCLUSION: Embedding this core set in future clinical trials will promote the standardisation of reporting to inform clinical practice. TWEETABLE ABSTRACT: A Delphi method identifying core outcomes for epilepsy in pregnancy. Final core set includes 31 outcomes.
© 2016 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  zzm321990CROWNzzm321990; Core outcomes; Delphi; epilepsy; pregnancy

Mesh:

Year:  2016        PMID: 27860117     DOI: 10.1111/1471-0528.14430

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  13 in total

1.  Development of a Core Outcome Set for research on critically ill obstetric patients: A study protocol.

Authors:  Julien Viau-Lapointe; Rohan D'Souza; Louise Rose; Stephen E Lapinsky
Journal:  Obstet Med       Date:  2018-05-14

2.  Adaptation of the WHO maternal near miss tool for use in sub-Saharan Africa: an International Delphi study.

Authors:  Abera K Tura; Jelle Stekelenburg; Sicco A Scherjon; Joost Zwart; Thomas van den Akker; Jos van Roosmalen; Sanne J Gordijn
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-29       Impact factor: 3.007

3.  Core Outcome Domains for early phase clinical trials of sound-, psychology-, and pharmacology-based interventions to manage chronic subjective tinnitus in adults: the COMIT'ID study protocol for using a Delphi process and face-to-face meetings to establish consensus.

Authors:  Kathryn Fackrell; Harriet Smith; Veronica Colley; Brian Thacker; Adele Horobin; Haúla F Haider; Alain Londero; Birgit Mazurek; Deborah A Hall
Journal:  Trials       Date:  2017-08-23       Impact factor: 2.279

Review 4.  Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries.

Authors:  Katherine Davis; Sarah L Gorst; Nicola Harman; Valerie Smith; Elizabeth Gargon; Douglas G Altman; Jane M Blazeby; Mike Clarke; Sean Tunis; Paula R Williamson
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

5.  Defining and evaluating novel procedures for involving patients in Core Outcome Set research: creating a meaningful long list of candidate outcome domains.

Authors:  Harriet Smith; Adele Horobin; Kathryn Fackrell; Veronica Colley; Brian Thacker; Deborah A Hall
Journal:  Res Involv Engagem       Date:  2018-03-02

6.  Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort.

Authors:  Kim Christian Danielsson; Nils Erik Gilhus; Ingrid Borthen; Rolv Terje Lie; Nils-Halvdan Morken
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

7.  Core Outcome Sets (COS) related to pregnancy and childbirth: a systematic review.

Authors:  Marie Österberg; Christel Hellberg; Ann Kristine Jonsson; Sara Fundell; Frida Trönnberg; Alkistis Skalkidou; Maria Jonsson
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-09       Impact factor: 3.007

8.  Developing, implementing and disseminating a core outcome set for neonatal medicine.

Authors:  James Webbe; Ginny Brunton; Shohaib Ali; James Mn Duffy; Neena Modi; Chris Gale
Journal:  BMJ Paediatr Open       Date:  2017-07-26

9.  Core outcome set for diabetes after pregnancy prevention across the life span: international Delphi study.

Authors:  Nancy Wu; Sharleen O'Reilly; Karoline Kragelund Nielsen; Helle Terkildsen Maindal; Kaberi Dasgupta
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11

10.  Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project).

Authors:  G B Langbroek; A Wolkerstorfer; S E R Horbach; P I Spuls; K M Kelly; S J Robertson; M I van Raath; F Al-Niaimi; T Kono; P Boixeda; H J Laubach; A M Badawi; A Troilius Rubin; M Haedersdal; W Manuskiatti; C M A M van der Horst; D T Ubbink
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-16       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.